US 11377478
T-cell modulatory multimeric polypeptides and methods of use thereof
granted A61KA61K2039/505A61K2039/55533
Quick answer
US patent 11377478 (T-cell modulatory multimeric polypeptides and methods of use thereof) held by Cue Biopharma, Inc. expires Mon Jun 30 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Cue Biopharma, Inc.
- Grant date
- Tue Jul 05 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 30 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K2039/505, A61K2039/55533, A61K35/17, A61K38/00